Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / GENOMIC REV ETF
-
Total 13F shares
-
22,230,141
-
Share change
-
+2,563,131
-
Total reported value
-
$668,316,409
-
Put/Call ratio
-
284%
-
Price per share
-
$30.07
-
Number of holders
-
287
-
Value change
-
+$77,890,388
-
Number of buys
-
99
-
Number of sells
-
134
Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q1 2023
As of 31 Mar 2023,
ARK ETF TR - GENOMIC REV ETF (ARKG) was held by
287 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,230,141 shares.
The largest 10 holders included
MORGAN STANLEY, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, BNP PARIBAS ARBITRAGE, SNC, CITIGROUP INC, LPL Financial LLC, STATE OF WISCONSIN INVESTMENT BOARD, GOLDMAN SACHS GROUP INC, UBS Group AG, and COMMONWEALTH EQUITY SERVICES, LLC.
This page lists
288
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.